Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 73,501 shares at $37.12 ($2.7M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $2.7M AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.12 | 24,400 | $906K | 33.2% |
| 2 | $37.12 | 24,401 | $906K | 33.2% |
| 3 | $37.13 | 24,700 | $917K | 33.6% |
| Total | $37.12 avg | 73,501 | $2.7M | 100% |
| Filing → |
| AIMT | SELL | 2018-01-04 | $1.8M | — | Filing → |
| AIMT | SELL | 2017-09-27 | $500K | — | Filing → |
| AIMT | SELL | 2017-09-07 | $405K | — | Filing → |